Vaxcyte Ownership | Who Owns Vaxcyte?


OverviewForecastFinancialsChartTranscripts

Vaxcyte Ownership Summary


Vaxcyte is owned by 31.26% institutional investors, 0.71% insiders, and 68.03% retail investors. Fmr is the largest institutional shareholder, holding 10.58% of PCVX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.91% of its assets in Vaxcyte shares.

PCVX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVaxcyte31.26%0.71%68.03%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr13.09M10.58%$1.07B
Vanguard group11.96M9.67%$979.18M
Blackrock funding, inc. /de11.11M8.98%$909.14M
Janus henderson group10.58M8.55%$865.61M
Blackrock9.94M8.48%$750.56M
Ra capital management8.69M7.02%$711.30M
Capital research global investors6.21M5.02%$508.39M
Wellington management group llp4.44M3.59%$363.79M
Price t rowe associates inc /md/3.97M3.21%$324.74M
State street3.37M2.87%$254.25M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Pivotal bioventure partners investment advisor703.83K38.91%$57.62M
Kynam capital management, lp2.34M11.31%$191.29M
Commodore capital lp1.63M9.75%$133.02M
Ra capital management8.69M9.47%$711.30M
Saturn v capital management204.28K6.55%$16.72M
Artia global partners lp162.25K4.75%$13.28M
First turn management276.90K4.06%$22.67M
Paradigm biocapital advisors lp1.42M4.05%$116.47M
Perceptive advisors1.72M3.88%$140.67M
Novo750.00K3.72%$61.40M

Top Buyers

HolderShares% AssetsChange
Goldman sachs group3.13M0.04%2.18M
Capital research global investors6.21M0.10%1.31M
Kynam capital management, lp2.34M11.31%1.30M
Norges bank1.10M0.01%1.10M
Westfield capital management co lp2.57M0.91%826.88K

Top Sellers

HolderShares% AssetsChange
Fmr13.09M0.06%-2.71M
Darwin global management---2.20M
T. rowe price investment management2.86M0.14%-1.19M
Fred alger management523.01K0.20%-720.71K
Cormorant asset management, lp425.00K1.91%-575.00K

New Positions

HolderShares% AssetsChangeValue
Norges bank1.10M0.01%1.10M$90.07M
Lazard asset management486.76K0.06%486.76K$39.85M
Hood river capital management401.44K0.49%401.44K$32.86M
Twinbeech capital lp279.94K0.39%279.94K$22.92M
Raymond james financial264.70K0.01%264.70K$21.67M

Sold Out

HolderChange
Global financial private client-1.00
Capital performance advisors llp-3.00
Hemington wealth management-11.00
Addison advisors-26.00
Lynx investment advisory-26.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024130-62.54%38,665,990-71.44%310.26%83-61.03%32-63.64%
Sep 30, 202434425.09%135,391,30510.49%1091.00%21032.08%8818.92%
Jun 30, 20242755.36%122,540,4573.83%1040.94%1597.43%74-6.33%
Mar 31, 202426114.47%118,023,70414.54%1050.94%14818.40%7916.18%
Dec 31, 202322811.22%103,039,9662.47%1061.08%12513.64%6817.24%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv3.75M2.91%2.35K
Vanguard US Total Market Shares ETF3.67M2.85%587.74K
iShares Russell 2000 ETF3.26M2.54%-28.27K
Vanguard Small Cap Index3.02M2.35%2.46K
Vanguard Health Care Inv2.55M2.04%-
American Funds SMALLCAP World A2.38M1.91%-
Janus Henderson Forty S1.98M1.54%459.38K
Capital Group Growth Fnd of Amer Comp1.91M1.53%906.75K
American Funds Growth Fund of Amer A1.91M1.53%906.75K
Vanguard Institutional Extnd Mkt Idx Tr1.75M1.36%2.44K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 05, 2025Eydelman Mikhail SVP, GEN COUNSEL & CORP SECSell$8.11K
Mar 05, 2025Eydelman Mikhail SVP, GEN COUNSEL & CORP SECSell$184.49K
Mar 05, 2025Eydelman Mikhail SVP, GEN COUNSEL & CORP SECSell$161.11K
Mar 03, 2025Wassil Jim CHIEF OPERATING OFFICERSell$153.95K
Mar 03, 2025Wassil Jim CHIEF OPERATING OFFICERSell$432.21K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1-32
2024 Q4-68
2024 Q3-54
2024 Q2-46

PCVX Ownership FAQ


Who Owns Vaxcyte?

Vaxcyte shareholders are primarily institutional investors at 31.26%, followed by 0.71% insiders and 68.03% retail investors. The average institutional ownership in Vaxcyte's industry, Biotech Stocks , is 68.48%, which Vaxcyte falls below.

Who owns the most shares of Vaxcyte?

Vaxcyte’s largest shareholders are Fmr (13.09M shares, 10.58%), Vanguard group (11.96M shares, 9.67%), and Blackrock funding, inc. /de (11.11M shares, 8.98%). Together, they hold 29.23% of Vaxcyte’s total shares outstanding.

Does Blackrock own Vaxcyte?

Yes, BlackRock owns 8.48% of Vaxcyte, totaling 9.94M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 750.56M$. In the last quarter, BlackRock increased its holdings by 426.84K shares, a 4.49% change.

Who is Vaxcyte’s biggest shareholder by percentage of total assets invested?

Pivotal bioventure partners investment advisor is Vaxcyte’s biggest shareholder by percentage of total assets invested, with 38.91% of its assets in 703.83K Vaxcyte shares, valued at 57.62M$.

Who is the top mutual fund holder of Vaxcyte shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Vaxcyte shares, with 2.91% of its total shares outstanding invested in 3.75M Vaxcyte shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools